title: Therapeutic effects of Holmium-166 chitosan complex in rat brain tumor model.
abstract: This study examined the effectiveness of Holmium-166 (Ho-166) chitosan complex therapy for a malignant glioma. Cultured C6 glioma cells (100,000 in 5 microl) were injected into the caudate/putamen of 200-250 gram Wistar rats. Five days later, a Ho-166 chitosan complex was injected into the same site of the glioma injection. Four injection doses were administered: the control group received PBS 10 microl, group 1 received an injection of 100 microCi (10 microl), group 2 received an injection of 50 microCi (5 microl), and group 3 received an injection of 10 microCi (1 microl). The average tumor volume for each group was 1.385 mm3 for the control group, 0.036 mm3 for group 1, 0.104 mm3 for group 2, and 0.111 mm3 for group 3. Compared with the control group, the size of the tumors in groups 1, 2 and 3 was reduced by an average of 97.4%, 92.5% and 91.9%, respectively. The Kaplan-Meier survival curve of group 2 was the longest, followed by groups 3, group 1 and the control. The mean survival was 22.8, 59, 60, and 44.6 days for the control group and groups 3, 2 and 1, respectively. H-E staining revealed that group 2 yielded the best results in the destruction of the malignant glioma. TUNEL staining and immunohistochemical studies indicated apoptotic features. The Ho-166 chitosan complex proved to be effective in destroying the malignant glioma.
authors.affiliation: Department of Neurosurgery, Yonsei University College of Medicine, 134 Shinchon-dong, Seodaemun- gu, Seoul 120-752, Korea.
authors.forename: Ryoong
authors.initials: R
authors.lastname: Huh
authors.forename: Yong Sook
authors.initials: YS
authors.lastname: Park
authors.forename: Jong Doo
authors.initials: JD
authors.lastname: Lee
authors.forename: Young Sun
authors.initials: YS
authors.lastname: Chung
authors.forename: Yong Gou
authors.initials: YG
authors.lastname: Park
authors.forename: Sang Sup
authors.initials: SS
authors.lastname: Chung
authors.forename: Jin Woo
authors.initials: JW
authors.lastname: Chang
mesh_terms: D000818:Animals; D001918:Brachytherapy; D001932:Brain Neoplasms / Q000000981:diagnostic imaging* / Q000401:mortality / Q000473:pathology; D045744:Cell Line, Tumor; D002686:Chitin / Q000031:analogs & derivatives / Q000494:pharmacology*; D004195:Disease Models, Animal; D005910:Glioma / Q000000981:diagnostic imaging* / Q000401:mortality / Q000473:pathology; D006695:Holmium / Q000494:pharmacology*; D011868:Radioisotopes / Q000494:pharmacology*; D011877:Radionuclide Imaging; D051381:Rats; D017208:Rats, Wistar
chemical_list: D011868:Radioisotopes; D002686:Chitin; D006695:Holmium
references.citation: Br J Neurosurg. 1999 Jun;13(3):256-64
references.pmid: 10562835
references.citation: J Neurosurg. 1999 Jan;90(1):125-32
references.pmid: 10413165
references.citation: Eur J Nucl Med. 2000 Jul;27(7):842-6
references.pmid: 10952496
references.citation: Neurosurgery. 2000 Oct;47(4):931-8; discussion 938-9
references.pmid: 11014433
references.citation: Int J Radiat Oncol Biol Phys. 2000 Oct 1;48(3):831-6
references.pmid: 11020581
references.citation: Cancer Treat Rev. 2000 Dec;26(6):397-409
references.pmid: 11139371
references.citation: J Neurosurg. 2000 Dec;93(6):917-26
references.pmid: 11117863
references.citation: J Neurooncol. 2000 Aug;49(1):27-39
references.pmid: 11131984
references.citation: Eur J Nucl Med. 2001 Apr;28(4):489-97
references.pmid: 11357500
references.citation: Neuro Oncol. 1999 Jan;1(1):69-80
references.pmid: 11550304
references.citation: Neurosurgery. 2002 Jan;50(1):41-6; discussion 46-7
references.pmid: 11844233
references.citation: Eur J Nucl Med Mol Imaging. 2002 Feb;29(2):221-30
references.pmid: 11926384
references.citation: Eur J Pharm Biopharm. 2004 Jan;57(1):123-31
references.pmid: 14729088
references.citation: Neurosurgery. 1987 Aug;21(2):201-6
references.pmid: 2821446
references.citation: Br J Neurosurg. 1989;3(2):197-210
references.pmid: 2803583
references.citation: Anticancer Res. 1991 Mar-Apr;11(2):719-27
references.pmid: 2064325
references.citation: J Nucl Med. 1991 Nov;32(11):2139-43
references.pmid: 1941151
references.citation: Neurosurgery. 1992 Aug;31(2):336-43
references.pmid: 1513439
references.citation: Neurosurgery. 1993 May;32(5):716-20; discussion 720
references.pmid: 8388081
references.citation: Neurosurgery. 1994 Nov;35(5):822-9; discussion 829-30
references.pmid: 7838329
references.citation: Stereotact Funct Neurosurg. 1995;64 Suppl 1:239-48
references.pmid: 8584834
references.citation: J Nucl Med. 1997 May;38(5):697-702
references.pmid: 9170430
references.citation: Arzneimittelforschung. 1998 Mar;48(3):300-4
references.pmid: 9553690
references.citation: J Nucl Med. 1998 Dec;39(12):2161-6
references.pmid: 9867162
references.citation: Neurosurgery. 2000 May;46(5):1123-8; discussion 1128-30
references.pmid: 10807244